Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells

Blood

Volumn 91, Issue 9, 1998, Pages 3390-3396

  Majolini, M Bernardetta ^b   D'Elios, Mario M ^b   Galieni, Piero ^b   Boncristiano, Marianna ^b   Lauria, Francesco ^b   Del Prete, Gianfranco ^b   Telford, John L ^b   Baldari, Cosima T ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SURVIVAL; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; ENZYME SPECIFICITY; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0032079509     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3390.3390_3390_3396     Document Type: Article

References (31)

1. Kipps TJ: Chronic lymphocytic leukemia and related diseases, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology. New York, NY, McGraw-Hill, 1995, p 1017
2. Kantor AB, Herzenberg LA: Origin of murine B-cell lineages. Annu Rev Immunol 11:501, 1993
3. Hardy RR, Hayakawa K: CD5 B cells, a fetal B cell lineage. Adv Immunol 55:297, 1994
4. Kantor AB: The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 12:389, 1991
5. Werner-Favre C, Vischer TL, Wohlwend D, Zubler RH: Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol 19:1209, 1989
6. Kantor AB, Stall AM, Adams S, Herzenberg LA: Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA 89:3320, 1992
7. Solvason N, Lehuen A, Kearny JF: An embryonic source of Ly1 but not conventional B cells. Int Immunol 3:543, 1991
8. +) B cells. Curr Opin Immunol 4:181, 1992
9. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL: Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 185:1035, 1997
10. Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87:2615, 1996
11. Lankester AC, van Schijndel GMW, van der School CE, van Oers MHJ, van Noesel CJM, van Lier RAW: Antigen receptor non responsiveness in chronic lymphocytic leukemia B cells. Blood 86: 1090, 1995
12. + antiporter has different properties in human B lymphocytes according to CD5 expression and malignant phenotype. Eur J Immunol 21:583, 1991
13. Michel F, Merle-Beral H, Michel A, Debré P, Bismuth G: Defective calcium response in B-chronic lymphocytic leukemia cells. J Immunol 150:3624, 1993
14. Cooper JA, Howell B: The when and how of Src regulation. Cell 73:1051, 1993
15. Bolen JB, Thompson PA, Eiseman E, Horak ID: Expression and interactions of the src family of protein tyrosine kinases in T lymphocytes. Adv Cancer Res 57:103, 1991
16. lck. Proc Natl Acad Sci USA 85:5190, 1991
17. Perussia B, Trinchieri G, Lebman D, Jankievicz J, Lange B, Rovera G: Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells. Blood 59:382, 1982
18. Baldari CT, Milia E, Di Somma MM, Baldoni F, Valitutti S, Telford JL: Distinct signaling properties identify functionally different CD4 epitopes. Eur J Immunol 25:1843, 1995
19. lck) during T-cell activation. Mol Cell Biol 8:4353, 1988
20. lac. Mol Cell Biol 14:2862, 1994
21. lac in thymopoiesis. EMBO J 12:1671, 1993
22. Karray S, Merle-Beral H, Vasquez A, Gerard A, Debré P, Galanud P: Functional heterogeneity of B-CLL lymphocytes: Dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood 70:1105, 1987
23. Schena M, Larsson MG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F: Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981, 1992
24. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
25. Miyasaki T, Liu ZJ, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Tanigushi T: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81:223, 1995
26. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K: The B-cell surface protein CD82/Lyb-2 is the ligand for Cd5. Nature 351:662, 1990
27. Wang F, Gregory D, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E: Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 84:3452, 1987
28. Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM: Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol 64:1002, 1990
29. Knutson JC: The level of c-fgr RNA is increased by EBNA 2, an Epstein-Barr virus gene required for B-cell immortalization. J Virol 64:2530, 1990
30. Straus DB, Weiss A: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585, 1992
31. Marth JD, Peet R, Krebs EG, Perlmutter RM: A lymphocyte-specific protein-tyrosine kinase is rearranged and overexpressed in the murine lymphoma LSTRA. Cell 43:393, 1985